Interpace Biosciences (IDXG) Reports Q4 EPS of $0.82

Interpace Biosciences (OTC: IDXG) reported Q4 EPS of $0.82.Revenue for the quarter came in at $9.22 million.

For earnings history and earnings-related data on Interpace Biosciences (IDXG) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Trump says North Korea's Kim responded to his outreach
• Wolfpack Research: 'we are short FTK because their $400m deal has been canceled'